Stericycle (NASDAQ:SRCL) Earns Hold Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Stericycle (NASDAQ:SRCL) in a report released on Wednesday. The brokerage issued a hold rating on the business services provider’s stock.

A number of other brokerages also recently weighed in on SRCL. Truist Financial raised their price objective on Stericycle from $50.00 to $62.00 and gave the company a hold rating in a research report on Tuesday, June 4th. Keefe, Bruyette & Woods raised their price target on shares of Stericycle from $135.00 to $142.00 and gave the company an outperform rating in a report on Tuesday, June 4th. Finally, Royal Bank of Canada reiterated a sector perform rating and set a $62.00 price objective (down previously from $69.00) on shares of Stericycle in a research note on Tuesday, June 4th. One analyst has rated the stock with a sell rating, four have issued a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, Stericycle presently has a consensus rating of Hold and an average target price of $74.00.

Stericycle Trading Up 0.1 %

NASDAQ SRCL opened at $60.95 on Wednesday. The company’s 50-day simple moving average is $59.63 and its two-hundred day simple moving average is $55.13. Stericycle has a one year low of $37.78 and a one year high of $61.77. The company has a market capitalization of $5.66 billion, a price-to-earnings ratio of -277.05, a price-to-earnings-growth ratio of 3.37 and a beta of 1.11. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.13 and a current ratio of 1.13.

Stericycle (NASDAQ:SRCL) last issued its quarterly earnings data on Thursday, July 25th. The business services provider reported $0.61 EPS for the quarter, topping analysts’ consensus estimates of $0.57 by $0.04. The company had revenue of $661.60 million during the quarter, compared to the consensus estimate of $672.07 million. Stericycle had a net margin of 1.37% and a return on equity of 7.94%. Equities analysts forecast that Stericycle will post 2.29 EPS for the current fiscal year.

Hedge Funds Weigh In On Stericycle

Several hedge funds and other institutional investors have recently modified their holdings of SRCL. Clearstead Trust LLC acquired a new position in Stericycle during the 1st quarter valued at approximately $25,000. International Assets Investment Management LLC purchased a new stake in shares of Stericycle during the second quarter valued at $45,000. GAMMA Investing LLC increased its position in shares of Stericycle by 170.9% in the 1st quarter. GAMMA Investing LLC now owns 818 shares of the business services provider’s stock valued at $43,000 after acquiring an additional 516 shares during the period. Headlands Technologies LLC purchased a new position in Stericycle in the 1st quarter worth $44,000. Finally, TFO Wealth Partners LLC raised its stake in Stericycle by 22,325.0% in the 4th quarter. TFO Wealth Partners LLC now owns 897 shares of the business services provider’s stock worth $44,000 after acquiring an additional 893 shares during the last quarter. 98.82% of the stock is owned by hedge funds and other institutional investors.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.